Single Dose Oral Bioequivalence Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets

Clinical trial NCT05417087 · COMPLETED

Trial details

NCT number: NCT05417087
Sponsor: Seasons Biotechnology (Taizhou) Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Major Depressive Disorder (MDD)

Start date: 2022-06-27
Primary completion: 2022-09-02
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.